Your browser doesn't support javascript.
loading
Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial.
Mackey, John R; Martin, Miguel; Pienkowski, Tadeusz; Rolski, Janusz; Guastalla, Jean-Paul; Sami, Amer; Glaspy, John; Juhos, Eva; Wardley, Andrew; Fornander, Tommy; Hainsworth, John; Coleman, Robert; Modiano, Manuel R; Vinholes, Jeferson; Pinter, Tamas; Rodríguez-Lescure, Alvaro; Colwell, Bruce; Whitlock, Pierre; Provencher, Louise; Laing, Kara; Walde, David; Price, Chris; Hugh, Judith C; Childs, Barrett H; Bassi, Kimberly; Lindsay, Mary-Ann; Wilson, Véronique; Rupin, Matthieu; Houé, Vincent; Vogel, Charles.
Affiliation
  • Mackey JR; Cross Cancer Institute, Edmonton, AB, Canada.
Lancet Oncol ; 14(1): 72-80, 2013 Jan.
Article in En | MEDLINE | ID: mdl-23246022
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Doxorubicin / Cyclophosphamide / Taxoids Type of study: Clinical_trials / Observational_studies / Prognostic_studies Limits: Adolescent / Adult / Aged / Female / Humans / Middle aged Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2013 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Doxorubicin / Cyclophosphamide / Taxoids Type of study: Clinical_trials / Observational_studies / Prognostic_studies Limits: Adolescent / Adult / Aged / Female / Humans / Middle aged Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2013 Document type: Article Affiliation country: Country of publication: